Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Weiss

Showing results (201-210 of 213) with videos related to

Pageof 22
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2017
Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In VitroDavid Pearson, H Markus Weiss, Yi Jin, et al.
RMD Open|August 14, 2025
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyNan Shen, Julia Weinmann-Menke, Ana Malvar, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 15, 2012
Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitroHans-Peter Gschwind, Ulrike Glaenzel, Felix Waldmeier, et al.
Cancers|November 26, 2022
Association between Intraoperative Blood Transfusion, Regional Anesthesia and Outcome after Pediatric Tumor Surgery for NephroblastomaSarah D Müller, Christian P Both, Christoph Sponholz, et al.
Paediatric Anaesthesia|October 18, 2016
Perioperative intravenous fluid therapy in children: guidelines from the Association of the Scientific Medical Societies in GermanyRobert Sümpelmann, Karin Becke, Sebastian Brenner, et al.
Chemistry & Biodiversity|December 29, 2006
Chemical and biological investigations of beta-oligoargininesDieter Seebach, Kenji Namoto, Yogesh R Mahajan, et al.
British Journal of Pharmacology|November 4, 2014
AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluationDominik Feuerbach, Nicole Pezous, Markus Weiss, et al.
Clinical and Translational Science|February 26, 2024
LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trialChristian Loesche, Damien Picard, Benjamin Van Hoorick, et al.
Alimentary Pharmacology & Therapeutics|November 27, 2025
Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction-Associated SteatohepatitisJuan Frias, Robert Schmouder, Eric Lawitz, et al.
Annals of Emergency Medicine|February 10, 2009
Predictors of airway and respiratory adverse events with ketamine sedation in the emergency department: an individual-patient data meta-analysis of 8,282 childrenSteven M Green, Mark G Roback, Baruch Krauss, et al.
Pageof 22

Showing results (201-210 of 213) with videos related to

Sort By:
Pageof 22
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2017
Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In VitroDavid Pearson, H Markus Weiss, Yi Jin, et al.
RMD Open|August 14, 2025
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyNan Shen, Julia Weinmann-Menke, Ana Malvar, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 15, 2012
Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitroHans-Peter Gschwind, Ulrike Glaenzel, Felix Waldmeier, et al.
Cancers|November 26, 2022
Association between Intraoperative Blood Transfusion, Regional Anesthesia and Outcome after Pediatric Tumor Surgery for NephroblastomaSarah D Müller, Christian P Both, Christoph Sponholz, et al.
Paediatric Anaesthesia|October 18, 2016
Perioperative intravenous fluid therapy in children: guidelines from the Association of the Scientific Medical Societies in GermanyRobert Sümpelmann, Karin Becke, Sebastian Brenner, et al.
Chemistry & Biodiversity|December 29, 2006
Chemical and biological investigations of beta-oligoargininesDieter Seebach, Kenji Namoto, Yogesh R Mahajan, et al.
British Journal of Pharmacology|November 4, 2014
AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluationDominik Feuerbach, Nicole Pezous, Markus Weiss, et al.
Clinical and Translational Science|February 26, 2024
LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trialChristian Loesche, Damien Picard, Benjamin Van Hoorick, et al.
Alimentary Pharmacology & Therapeutics|November 27, 2025
Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction-Associated SteatohepatitisJuan Frias, Robert Schmouder, Eric Lawitz, et al.
Annals of Emergency Medicine|February 10, 2009
Predictors of airway and respiratory adverse events with ketamine sedation in the emergency department: an individual-patient data meta-analysis of 8,282 childrenSteven M Green, Mark G Roback, Baruch Krauss, et al.
Pageof 22